Vildagliptin Racemic

CAS: 1360862-63-0

Ref. TR-V305028

Produktinformation

• Name: Vildagliptin Racemic
• Synonyme: 1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2-pyrrolidinecarbonitrile (ACI), 1-[2-[(3-Hydroxyadamantan-1-yl)amino]acetyl]pyrrolidine-2-carbonitrile, 2-Pyrrolidinecarbonitrile, 1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]- (ACI

Beschreibung

Applications Vildagliptin Racemic is an impurity of Vildagliptin (V305000),a class of oral anti-hyperglycemic agents that inhibit dipeptidyl peptidase 4 (DPP-4), which can act as a serine exopeptidase. Aside from their use in type 2 diabetes, gliptins have positive cardiovascular and anti-inflammtatory effects. Antidiabetic.
References Ahren, B., et al.: J. Clin. Endocrinol. Metab., 89, 2078 (2004), Ahren, B., et al.: Diabetes Care, 27, 2874 (2004), Barlocco, D., et al.: Curr. Opin. Invest. Drugs, 5, 1094 (2004),

• Marke: TRC

Chemische Eigenschaften

• Molekulargewicht: 303.399
• Formel: C₁₇H₂₅N₃O₂
• Farbe/Form: Neat
• InChl: InChI=1S/C17H25N3O2/c18-9-14-2-1-3-20(14)15(21)10-19-16-5-12-4-13(6-16)8-17(22,7-12)11-16/h12-14,19,22H,1-8,10-11H2
• InChI Key: InChIKey=WOWDLLLNIGXFFA-ZGDAAODBSA-N
• SMILES: N#CC1CCCN1C(=O)CN[C@@]12C[C@@H]3C[C@@H](C[C@@](O)(C3)C1)C2